Growth Hormone Secretagogues

Sermorelin

GRH 1-29 · GHRH analogue

A bioidentical fragment of GHRH (amino acids 1–29) that stimulates natural, pulsatile growth hormone release.

Overview & Mechanism

Binds GHRH receptors on the pituitary to stimulate endogenous GH secretion in a physiological, pulsatile pattern, preserving feedback regulation.

Research Dosage

Dose

200–500 mcg/day

Route

Subcutaneous injection

Frequency

Once daily (before bed)

Cycle

3–6 months

Reconstitution & Storage

Reconstitution

Reconstitute per vial with bacteriostatic water. Sermorelin is less stable; use promptly.

Storage

Lyophilized: refrigerate 2–8 °C. Reconstituted: refrigerate and use within ~14 days.

Safety & Side Effects

Generally well tolerated; injection-site reactions and flushing possible. Preserves GH feedback axis.

Studies

Sermorelin for adult GH deficiency

Sermorelin stimulated GH and IGF-1 increases in adults with age-related GH decline, supporting its use in GH restoration.

Read study

References

Research Use Only

This information is intended for licensed researchers and educational purposes only. It does not constitute medical advice. PureLife Health products are not approved for human use by Health Canada or the FDA. Always consult a qualified medical professional and verify against current literature.